Fundz

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, Its Second Generation COVID-19 Vaccine

PRIVATEDec 18, 2020

Amount Raised

€5.2 Million

Round Type

Funding Round

NantesBiotechnologyHealth Care

Description

Regulatory News:

Quick answer

OSE Immunotherapeutics raised €5.2 Million in a Funding Round round, dated December 18, 2020. OSE Immunotherapeutics is based in Nantes, Pays De La Loire, France.

How much did OSE Immunotherapeutics raise?
OSE Immunotherapeutics raised €5.2 Million in a Funding Round round on December 18, 2020.
What does OSE Immunotherapeutics do?
OSE Immunotherapeutics SA is a biopharmaceutical company that announced a major expansion of its partnership with Boehringer Ingelheim.
Where is OSE Immunotherapeutics based and how big is it?
OSE Immunotherapeutics is based in Nantes, Pays De La Loire, France. Fundz records about 83 employees.
Who are the decision-makers at OSE Immunotherapeutics?
Fundz holds 2 contacts at OSE Immunotherapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as OSE Immunotherapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at OSE Immunotherapeutics, and when

A new round usually means OSE Immunotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OSE Immunotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OSE Immunotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OSE Immunotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OSE Immunotherapeutics

Location

Nantes, Pays De La Loire, France

About

OSE Immunotherapeutics SA is a biopharmaceutical company that announced a major expansion of its partnership with Boehringer Ingelheim. The company is excited about adding highly innovative new development programs to its fruitful collaboration with Boehringer Ingelheim, with a focus on bringing new breakthrough therapy options to patients with cardio-renal-metabolic diseases and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OSE Immunotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for OSE Immunotherapeutics's next move

See what Strategic adds

OSE Immunotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.